Figure 1 (Gammagard001)
Gammagard Liquid Erc Injection, Solution
Product Images NDC 0944-2705
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Gammagard Liquid Erc (NDC 0944-2705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 10 (Gammagard0010)
Figure 11 (Gammagard0011)
Figure 12 (Gammagard0012)
Figure 13 (Gammagard0013)
Figure 2 (Gammagard002)
Figure 3 (Gammagard003)
Figure 4 (Gammagard004)
Figure 5 (Gammagard005)
Figure 6 (Gammagard006)
Figure 7 (Gammagard007)
Figure 8 (Gammagard008)
Figure 9 (Gammagard009)
Principal Display Panel (10 mL Bottle Label)
This is a description for an immune globulin infusion medication called GAMMAGARD LIQUID ERC, a 10% solution for infusion. It is suitable for intravenous or subcutaneous administration and contains less than or equal to 2 pg/mL IgA. The medication is not made with natural rubber latex and should be stored refrigerated at 2° to 8°C (36° to 46°F) without freezing. It can also be stored at room temperature of up to 25°C (77°F). The manufacturer is Takeda Pharmaceuticals USA, Inc. and it is for prescription use only. This text also includes various product codes and contact information.*
Principal Display Panel (10 mL Bottle Carton)
This is a description of a medical product called GAMMAGARD LIQUID ERC, an Immune Globulin Infusion made from human plasma. It is a 10% solution for intravenous or subcutaneous administration. The product is stabilized with glycine and contains less than or equal to 2ug/mL IgA. The packaging includes a single-dose vial with 50mL and comes with prescribing information. It is important to note that products made from human plasma may contain infectious agents, and therefore, the patient and physician should discuss the risks and benefits of using this product. Please refer to the enclosed prescribing information for directions on usage and storage instructions.*
Principal Display Panel (25 mL Bottle Label)
This text provides information about a single-dose vial of Immune Globulin Infusion (Human) known as GAMMAGARD LIQUID ERC 10% Solution for Infusion. It mentions that the product contains less than or equal to 2 pg/mL IgA and can be administered intravenously or subcutaneously. The storage instructions include refrigeration at 2° to 8°C (36° to 46°F) and a maximum room temperature of up to 25°C (77°F). The text also includes details such as the manufacturer Takeda Pharmaceuticals, lot number, and other relevant identifiers.*
Principal Display Panel (25 mL Bottle Carton)
This is a description of a medication called GAMMAGARD LIQUID ERC, which is an immune globulin infusion solution for intravenous or subcutaneous administration. It is a 10% solution for infusion with less than or equal to 2 ug/mL IgA content. The product is stabilized with 0.25M glycine and does not contain preservatives or natural rubber latex. It is advised to store the product in a refrigerator between 2°C to 8°C (36°F to 46°F) and not to freeze it. The prescribing information provides directions for use and highlights the risks and benefits of the product, which is made from human plasma and may contain infectious agents.*
Figure 1 (Gammagard1)
Figure 2 (Gammagard2)
Figure 3 (Gammagard3)
Figure 4 (Gammagard4)
Figure 5 (Gammagard5)
Figure 6 (Gammagard6)
Figure 7 (Gammagard7)
Figure 8 (Gammagard8)
Figure 9 (Gammagard9)
Logo (Logo)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
